Related Experiment Videos
Neonatal ventriculosubgaleal shunts.
B B Fulmer1, P A Grabb, W J Oakes
1Division of Neurosurgery, University of Alabama-Birmingham, USA.
Neurosurgery
|August 5, 2000
Summary
Ventriculosubgaleal (VSG) shunts provide a safe temporary solution for hydrocephalus in neonates when other methods are unsuitable. While effective, most infants eventually require a permanent ventriculoperitoneal shunt.
Area of Science:
- Pediatric Neurosurgery
- Neonatal Care
- Hydrocephalus Management
Background:
- Hydrocephalus in neonates presents complex management challenges.
- Ventriculoperitoneal shunts are standard but not always immediately feasible.
- Alternative temporary CSF diversion methods are crucial for unstable infants.
Purpose of the Study:
- To evaluate the survival rates and complications of ventriculosubgaleal (VSG) shunts.
- To assess the efficacy of VSG shunts as a temporizing measure in neonates.
- To determine the long-term outcomes for infants treated with VSG shunts.
Main Methods:
- Retrospective analysis of 37 ventriculosubgaleal (VSG) shunts placed in 32 neonates between 1993 and 1997.
- VSG shunts were used when cerebrospinal fluid (CSF) or abdominal conditions precluded ventriculoperitoneal shunt placement.
- Shunts involved a ventricular catheter connected to a subgaleal pocket.
Main Results:
- The average VSG shunt survival was 35.1 days, with no infections.
- Complications included CSF leakage, catheter displacement, and one immediate post-revision death.
- All 24 surviving infants followed for 4 months required a subsequent ventriculoperitoneal shunt.
Conclusions:
- Ventriculosubgaleal (VSG) shunts are a simple, effective, and relatively safe temporary option for neonatal hydrocephalus.
- VSG shunts avoid external drainage or aspiration in medically unstable infants.
- They serve as a bridge until conditions are suitable for ventriculoperitoneal shunting.